Gonorrhea Figures
Previous Page Next Page: Syphilis
Figure 14. Gonorrhea—Rates, United States, 1941–2009
Figure 15. Gonorrhea—Rates by Sex, United States, 1990–2009
Figure 16. Gonorrhea—Rates by Region, United States, 2000–2009
Figure 17. Gonorrhea—Rates by State, United States and Outlying Areas, 2009
Figure 18. Gonorrhea—Rates by County, United States, 2009
Figure 19. Gonorrhea—Rates by Age and Sex, United States, 2009
Figure 20. Gonorrhea—Rates by Age Among Women Aged 15–44 Years,
United States, 2000–2009
Figure 21. Gonorrhea—Rates by Age Among Men Aged 15–44 Years,
United States, 2000–2009
Figure 22. Gonorrhea—Rates by Race/Ethnicity, United States, 2000–2009
Figure 23. Gonorrhea—Cases by Reporting Source and Sex, United States, 2000–2009
Figure 24. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting
Sources, United States, 2009
Figure 25. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2009
Figure 26. Gonococcal Isolate Surveillance Project (GISP)—Location of Participating Sentinel Sites and Regional Laboratories, United States, 2009
Figure 27. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum
Inhibitory Concentrations (MICs) to Ceftriaxone Among GISP
Isolates, 2005–2009
Figure 28. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum
Inhibitory Concentrations (MICs) to Cefixime Among GISP Isolates,
2005–2006 and 2009
Figure 29. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum
Inhibitory Concentrations (MICs) to Azithromycin Among GISP
Isolates, 2005–2009
Figure 30. Gonococcal Isolate Surveillance Project (GISP)—Percentage of Neisseria gonorrhoeae Isolates with Resistance or Intermediate Resistance to Ciprofloxacin, 1990–2009
Figure 31. Gonococcal Isolate Surveillance Project (GISP)—Penicillin, Tetracycline, and Ciprofloxacin Resistance Among GISP Isolates, 2009
Figure 32. Gonococcal Isolate Surveillance Project (GISP)—Drugs Used to Treat Gonorrhea Among GISP Participants, 1988–2009View all Gonorrhea figures as a slideshow[PPT 1.63MB]
Previous Page Next Page: Syphilis
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO
